Left atrio-oesophageal fistula after atrial fibrillation ablation

  1. Vishesh Paul 1,
  2. Rajamurugan Meenakshisundaram 2,
  3. Abdur R Jamal 3 and
  4. Talha Bin Farooq 2
  1. 1 Pulmonary & Critical Care Medicine, Carle Foundation Hospital, Urbana, Illinois, USA
  2. 2 Internal Medicine, Carle Foundation Hospital, Urbana, Illinois, USA
  3. 3 Vascular Surgery, Carle Foundation Hospital, Urbana, Illinois, USA
  1. Correspondence to Dr Vishesh Paul; visheshpaul@gmail.com

Publication history

Accepted:11 Nov 2020
First published:09 Dec 2020
Online issue publication:09 Dec 2020

Case reports

Case reports are not necessarily evidence-based in the same way that the other content on BMJ Best Practice is. They should not be relied on to guide clinical practice. Please check the date of publication.

Abstract

We report a case of a 68-year-old woman who presented with atypical chest pain and fluctuating neurological symptoms 4 weeks after cryoballoon ablation procedure for atrial fibrillation. Brain imaging showed multiple embolic infarcts, while the chest imaging revealed an abnormal connection between the posterior wall of the left atrium and the oesophagus. Based on her clinical presentation and the imaging findings, a diagnosis of left atrio-oesophageal fistula (AOF) was established. AOF carries a high mortality rate unless an urgent surgical repair is performed. Oesophageal instrumentation for an echocardiogram or endoscopy should be avoided as it can result in massive air embolus, causing stroke or death.

Background

Atrial fibrillation is one of the most common arrhythmias and is often successfully managed with medical treatment. In specific scenarios, patients need an interventional approach involving isolating the pulmonary veins around their ostia using catheter ablation. The complication rate of the procedure is low, and some of them include pericardial effusion, stroke, vascular injuries, phrenic nerve palsy, pulmonary vein stenosis and atrio-oesophageal fistula (AOF).1

AOF is a rare but potentially life-threatening complication of the ablation procedure that manifests 1–8 weeks after the procedure.1 High clinical suspicion, early diagnostic and treatment interventions are needed to prevent a fatal outcome. We present a case of AOF presenting with weakness and stroke symptoms, 4 weeks after cryoballoon ablation performed for uncontrolled atrial fibrillation.

Case presentation

A 68-year-old woman with a medical history of diabetes milletus, atrial fibrillation and obstructive sleep apnea presented to the emergency department because of weakness, lethargy, vague chest discomfort and multiple falls in the last 2 days. She had recently been given a course of azithromycin for a non-productive cough and subjective fevers, without much help. She also reported fluctuating weakness of the left side of the body. Four weeks earlier, she had undergone a cryoballoon ablation procedure for uncontrolled atrial fibrillation with medical therapy. She had been feeling weak and experiencing a vague chest discomfort since the procedure. She denied any headaches, seizures, numbness, loss of consciousness, nausea or vomiting.

On examination, she was awake, alert and oriented, had mild tachypnoea, but was able to speak in full sentences. Her vital signs included a temperature of 102.8°F, blood pressure of 98/51 mm Hg, pulse rate of 70/min, respiratory rate of 18/min and 90% oxygen saturation on room air. Lung auscultation revealed few crackles at the lung bases. The cardiac rhythm was regular, and there was no murmur. She had motor weakness of the left side (2/5 strength) but no sensory deficits. Interestingly, her motor weakness had entirely resolved on the physical examination performed a few hours later.

Investigations

Laboratory testing showed normal complete blood counts (white blood cells: 5×109/L) and serum chemistries but elevated lactic acid (3.1 mmol/L) and procalcitonin levels (28.5 ng/mL). Chest X-ray showed mild interstitial oedema, but no significant infiltrates. Due to the neurological symptoms and ongoing fever and cough, CT scans of the brain and chest were performed. CT chest showed an air collection in the mediastinum between the posterior left atrial wall and the oesophagus, suspicious for a fistula (figure 1). CT brain performed in the emergency room did not reveal any acute process. However, due to fluctuating neurological symptoms, an MRI brain was performed the next morning and showed acute infarction in the bilateral frontoparietal regions, suggestive of an embolic phenomenon (figure 2). An oesophagogram (using gastrograffin) performed to look for any oesophageal leak into the mediastinum was negative.

Figure 1

CT scan of the chest showing the fistula between the oesophagus and posterior wall of the left atrium (red arrow).

Figure 2

MRI of the brain showing the areas of embolic infarction (arrows).

Differential diagnosis

Pneumonia was considered based on cough, fever and elevated procalcitonin levels, but chest imaging did not show any infiltrates. Acute ischaemic and haemorrhagic stroke were also in the differential list, but brain imaging ruled them out. AOF leading to air embolism was confirmed based on the history of recent catheter ablation, imaging showing fistula between the left atrium and the oesophagus, and MRI brain suggesting embolic phenomena.

Treatment

Broad-spectrum antibiotics were initiated to treat mediastinitis. Our initial plan was to perform an upper endoscopy to look for the site of oesophageal injury and place a stent if needed. However, the cardiothoracic team strongly advised against the endoscopy procedure (explained in the Discussion section). The patient was transferred to a tertiary care centre for surgical management of the AOF. She underwent right thoracotomy for oesophageal mobilisation, the takedown of fistula and the primary repair of oesophageal perforation. The surgeon used the intercostal muscle flaps to reinforce the oesophagus.

Over the next few days in the intensive care unit, she received mechanical ventilation, parenteral nutrition and intravenous antibiotics (ampicillin–sulbactam). She was successfully extubated after 48 hours and placed on a nasal cannula. Oral intake was initiated after another normal oesophagogram. Over the next few days, she completed the antibiotic course, came off supplemental oxygen and parenteral nutrition.

Outcome and follow-up

The patient got discharged to a rehabilitation facility after 10 days of hospitalisation. After completing the rehabilitation, she successfully went home and continues to follow-up in the clinic for her other comorbidities.

Discussion

Catheter ablation is an established treatment for atrial fibrillation not controlled with medical therapy alone. Nowadays, it is being used early in the disease process, as studies have shown it to be equally, if not more effective, than antiarrhythmic therapy.2 Cryoballoon (freezing) and radiofrequency (thermal based) are two techniques used with similar success rates.3 AOF is a rare complication of the ablation procedure with reported incidence rates of 0.1%–0.25%.2 4 5 This serious complication has been most frequently reported with radiofrequency ablation, although the cryoballoon ablation technique can also cause it.4 As the oesophagus courses along the left atrium’s posterior wall, it’s at risk of injury with the ablation procedure. The process starts with thermal and ischaemic damage to the oesophagus at the time of the procedure.4 Studies have found oesophageal injuries on endoscopy performed soon after the ablation procedure in up to 15%–20% of patients.4 5 In a few patients, the damage progresses to perforation and fistula formation over the next few days due to swallowing and reflux. Hence, there is often a delay of a few weeks from the initial procedure to the presentation. The fistula usually acts as one-way communication from the oesophagus to the atrium.4 The most common manifestations are fever, chills, stroke (air or septic emboli), septic shock or sudden death.5

Early diagnosis can be easily missed as the connection between the patient’s symptoms and the procedure performed a few weeks ago can be overlooked, and a lack of awareness of this complication. Hence a detailed history and a high index of suspicion are required for a timely diagnosis. CT or MRI of the chest is the best diagnostic modality to identify the fistula. Oesophagogram has low sensitivity and does not add much information, as seen in our case. Brain CT or MRI often shows the embolic phenomena if neurological symptoms are present. If an AOF is suspected, oesophageal instrumentation for endoscopy or echocardiogram should be avoided since the insufflation of the oesophagus with air during the procedure may result in a massive air embolus producing stroke or death.5 The mortality rate of AOF is close to 100% if left untreated. Urgent surgical repair is the mainstay of treatment and has shown the best outcomes.4–6 Endoscopy with oesophageal stenting may lead to success in some cases but has a high risk of complications.4 Many physicians routinely prescribe proton pump inhibitors to the patients after the ablation to reduce the likelihood of this dreaded complication, though supporting evidence is lacking.4 Importantly, all patients undergoing ablation procedure must be educated about the warning signs and immediately contact their physician if any worrisome symptoms develop.

Learning points

  • Atrio-oesophageal fistula is a delayed but life-threatening complication of ablation procedures for atrial fibrillation.

  • A detailed history and high index of suspicion are required to establish a timely diagnosis.

  • Endoscopy or transoesophageal echocardiogram should be avoided as they can cause a large volume of air to embolise into the circulation.

  • Urgent surgical repair at a specialised centre is needed to prevent mortality.

Footnotes

  • Twitter @visheshpaul83

  • Contributors VP took care of the patient, wrote part of the manuscript and provided the final edited version. RM, ARJ, TBF did the literature search and wrote parts of the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

  • Provenance and peer review Not commissioned; externally peer-reviewed.

References

Use of this content is subject to our disclaimer